Advertisement

InFo Hämatologie + Onkologie

, Volume 22, Issue 11, pp 27–30 | Cite as

Schwerpunkt Pankreaskarzinom

Chirurgie des Pankreaskarzinoms — aufwendig aber erfolgreich

  • Ihsan Ekin DemirEmail author
  • Marc E. Martignoni
  • Helmut Friess
  • Alexander R. Novotny
Schwerpunkt
  • 9 Downloads

Die vollständige Resektion ist beim Pankreaskarzinom noch immer ein entscheidendes aber anspruchsvolles Therapieziel. Das liegt unter anderem daran, dass der Tumor meist wichtige intraabdominelle Venen, Arterien und Nerven befällt. Was das konkret bedeutet und wie sich chirurgisch damit umgehen lässt, lesen Sie in dieser kurzen Übersicht.

Literatur

  1. 1.
    Conroy T et al. FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer. N Engl J Med. 2018;379(25):2395–406CrossRefGoogle Scholar
  2. 2.
    Wang X et al. Venous resection during pancreatectomy for pancreatic cancer: a systematic review. Transl Gastroenterol Hepatol. 2019;4:46CrossRefGoogle Scholar
  3. 3.
    Mollberg N et al. Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg. 2011;254(6):882–93CrossRefGoogle Scholar
  4. 4.
    Klaiber U et al. Radical pancreatic cancer surgery-with arterial resection. Transl Gastroenterol Hepatol. 2019;4:8CrossRefGoogle Scholar
  5. 5.
    Klompmaker S et al. Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study. Ann Surg Oncol. 2018;25(5):1440–7CrossRefGoogle Scholar
  6. 6.
    Kim PT et al. Low Measured Hepatic Artery Flow Increases Rate of Biliary Strictures in Deceased Donor Liver Transplantation: An Age-Dependent Phenomenon. Transplantation. 2017;101(2):332–40CrossRefGoogle Scholar
  7. 7.
    Marin-Gomez LM et al. Intraoperative hepatic artery blood flow predicts early hepatic artery thrombosis after liver transplantation. Transplant Proc. 2012;44(7):2078–81CrossRefGoogle Scholar
  8. 8.
    Del Chiaro M et al. Pancreatectomy with arterial resection is superior to palliation in patients with borderline resectable or locally advanced pancreatic cancer. HPB (Oxford). 2019;21(2):219–25CrossRefGoogle Scholar
  9. 9.
    Sonohara F et al. Novel implications of combined arterial resection for locally advanced pancreatic cancer in the era of newer chemo-regimens. Eur J Surg Oncol. 2019;45(10):1895–900CrossRefGoogle Scholar
  10. 10.
    Gebauer F et al. Oligometastasis in pancreatic cancer: Current state of knowledge and spectrum of local therapy. Chirurg. 2018;89(7):510–5CrossRefGoogle Scholar
  11. 11.
    Hackert T et al. Radical surgery of oligometastatic pancreatic cancer. Eur J Surg Oncol. 2017;43(2):358–63CrossRefGoogle Scholar
  12. 12.
    Tachezy M et al. Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis. Surgery. 2016;160(1):136–44CrossRefGoogle Scholar
  13. 13.
    Reames BN et al. Management of Locally Advanced Pancreatic Cancer: Results of an International Survey of Current Practice. Ann Surg. 2019;  https://doi.org/10.1097/SLA.0000000000003568Google Scholar
  14. 14.
    Dobiasch S et al. Essential role of radiation therapy for the treatment of pancreatic cancer: Novel study concepts and established treatment recommendations. Strahlenther Onkol. 2018;194(3):185–95CrossRefGoogle Scholar
  15. 15.
  16. 16.
    Verbeke C et al. Pathology reporting of pancreatic cancer following neoadjuvant therapy: challenges and uncertainties. Cancer Treat Rev. 2015;41(1):17–26CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  • Ihsan Ekin Demir
    • 1
    Email author
  • Marc E. Martignoni
    • 1
  • Helmut Friess
    • 1
  • Alexander R. Novotny
    • 1
  1. 1.Klinik und Poliklinik für ChirurgieKlinikum rechts der Isar der Technischen Universität MünchenMünchenDeutschland

Personalised recommendations